viernes, 7 de noviembre de 2025

Kennedy, a longtime pharma critic, embraces Trump deal to expand access to obesity drugs Health secretary calls medicines like Wegovy a welcome ‘tool,’ disappointing some MAHA followers

https://www.statnews.com/2025/11/06/rfk-jr-reverses-course-glp-1-drugs-maha-faithful-reacts/

No hay comentarios: